Drivers of revenue growth included more customers using multiple chronic condition programs as well as strong adoption of GLP ...

Equities research analysts at Morgan Stanley assumed coverage on shares of Omada Health (NASDAQ:OMDA – Get Free Report) in a research report issued on Tuesday, MarketBeat reports. The firm set ...

In its first public earnings call after its initial public offering in June, virtual chronic disease provider Omada Health ...

Analysts at Needham & Company LLC began coverage on shares of Omada Health (NASDAQ:OMDA – Get Free Report) in a report released on Tuesday, Marketbeat reports. The brokerage set a “buy ...

Omada Health (OMDA) is a strong buy. Backed by 29 studies, key partnerships with Cigna and CVS drive growth, credibility, and market expansion. See more here.

Revenue of $61 million, up 49%52%Member Growth and Significant Progress Toward Profitability SAN FRANCISCO, Aug. 07, 2025 (GLOBE NEWSWIRE) --  Omada Health, Inc. (Nasdaq: OMDA), the virtual ...

He stressed that the Omada platform is designed to be an open-ended system that customizes itself based on the user’s specific health needs. “The reality is that obesity-related diseases tend to ...